Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Transformation-associated Recombination (TAR) Cloning and Its Applications

News

January 8, 2024
PRESS RELEASE: On December 22, 2023, a new review was published in Oncotarget, entitled, “Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine.” continue reading »

Therapeutically Harnessing Cancer Stem Cell-derived Exosomes

News

January 3, 2024
PRESS RELEASE: On December 20, 2023, a new editorial was published in Oncotarget: “Therapeutically harnessing cancer stem cell-derived exosomes.” continue reading »

Management of Refractory or Relapsed Classic Hodgkin Lymphoma in Brazil

News

December 20, 2023
PRESS RELEASE: On December 12, 2023, a new review was published in Oncotarget, entitled, “Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in Brazil: Balancing efficacy, safety, and tolerability.” continue reading »

Immunotherapy Response in Primary vs Metastatic Pancreatic Cancer

Oncotarget

November 16, 2023
In this editorial, researchers delve into the immunotherapeutic challenges posed by the tumor microenvironment and liver metastasis in pancreatic cancer. continue reading »

Obesity Paradox and Lung Cancer, Metformin-based Therapeutic Opportunity?

News

November 15, 2023
PRESS RELEASE: On March 31, 2023, a new editorial was published in Oncotarget, entitled, “Obesity paradox and lung cancer, metformin-based therapeutic opportunity?” continue reading »